A supplier you can audit.
BioXgen supplies synthetic research peptides to laboratories, universities and research companies across the EU. We are a supply and quality-control operation, not a manufacturer — and we think being clear about that is the point.
What we do
We qualify contract manufacturers, buy synthesis to specification, and take responsibility for what happens next: independent testing, lot release, documentation and cold-chain fulfilment. Every vial we ship carries a lot number that resolves to a certificate on this site.
What we do not do
We do not synthesise peptides ourselves, and we do not claim to. We do not advise on dosing, human use or therapeutic application, and we decline those enquiries. We do not sell lots that failed specification at a lower grade.
Why documentation first
In this category the analytical paperwork is usually available on request, behind an account, or not at all. We publish it by default because a research purchase you cannot document is a research purchase you cannot cite.
Where we operate
Stock is held and fulfilled inside the EU. The Danish operation serves Denmark and the Nordics; a German operation serves the DACH region; a third storefront serves the rest of the EU. One catalogue, one quality process, three markets.
Testing partners
Contact
Written enquiries only, in English or Danish. Technical questions about analytics or documentation reach the quality team directly.
All materials are supplied strictly for in-vitro laboratory research. They are not medicinal products, not food supplements, and not for human or veterinary administration.